作者
Marco Gallo,Fiona J. Coutinho,Robert Vanner,Tenzin Gayden,Stephen C. Mack,Alex Murison,Marc Remke,Ren Li,Nobuki Takayama,Kinjal Desai,Lilian Lee,Xiaoyang Lan,Nicole I. Park,Dalia Baršytė-Lovejoy,D. Smil,Dominik Sturm,Michelle Kushida,Renee Head,Michael D. Cusimano,Mark Bernstein,Ian D. Clarke,John E. Dick,Stefan M. Pfister,Jeremy Rich,C.H. Arrowsmith,Michael D. Taylor,Nada Jabado,David P. Bazett-Jones,Mathieu Lupien,Peter B. Dirks
摘要
Mutations in the histone 3 variant H3.3 have been identified in one-third of pediatric glioblastomas (GBMs), but not in adult tumors. Here we show that H3.3 is a dynamic determinant of functional properties in adult GBM. H3.3 is repressed by mixed lineage leukemia 5 (MLL5) in self-renewing GBM cells. MLL5 is a global epigenetic repressor that orchestrates reorganization of chromatin structure by punctuating chromosomes with foci of compacted chromatin, favoring tumorigenic and self-renewing properties. Conversely, H3.3 antagonizes self-renewal and promotes differentiation. We exploited these epigenetic states to rationally identify two small molecules that effectively curb cancer stem cell properties in a preclinical model. Our work uncovers a role for MLL5 and H3.3 in maintaining self-renewal hierarchies in adult GBM.